Private label food company TreeHouse Foods (NYSE:THS) announced better-than-expected revenue in Q2 CY2025, with sales up 1.2% year on year to $798 million. The company expects next quarter’s revenue to be around $855 million, close to analysts’ estimates. Its non-GAAP profit of $0.17 per share was 47.1% above analysts’ consensus estimates.
Bristol-Myers Squibb (BMY) offers a high 5.06% dividend yield, strong profitability, and solid financial health, making it a top pick for income investors. Its undervalued stock and consistent payout growth add to its appeal.
Packaging and materials company International Paper (NYSE:IP) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 42.9% year on year to $6.77 billion. Its non-GAAP profit of $0.20 per share was 51.1% below analysts’ consensus estimates.
Freight delivery company XPO (NYSE:XPO) beat Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $2.08 billion. Its non-GAAP profit of $1.05 per share was 6.2% above analysts’ consensus estimates.
Aerospace and defense company Howmet (NYSE:HWM) announced better-than-expected revenue in Q2 CY2025, with sales up 9.2% year on year to $2.05 billion. The company expects next quarter’s revenue to be around $2.03 billion, close to analysts’ estimates. Its non-GAAP profit of $0.91 per share was 4.2% above analysts’ consensus estimates.
The chip designer's results and guidance were not good enough to support its highly valued stock, but its attractive business model makes it worth watching.
WESCO International (WCC) beats Q2 2025 earnings estimates with strong data center sales exceeding $1B, driving revenue and EPS growth. Stock gains reflect investor optimism.
Lifting and material handling equipment company Terex (NYSE:TEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.6% year on year to $1.49 billion. The company’s full-year revenue guidance of $5.4 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.49 per share was 6.5% above analysts’ consensus estimates.
XPO Inc. reports mixed Q2 2025 earnings with revenue slightly beating estimates at $2.08B, while EPS declines. Shares rise pre-market, but broader sentiment remains cautious.
Infrastructure solutions provider Quanta (NYSE:PWR) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 21.1% year on year to $6.77 billion. The company’s full-year revenue guidance of $27.65 billion at the midpoint came in 2.4% above analysts’ estimates. Its non-GAAP profit of $2.48 per share was 1.4% above analysts’ consensus estimates.
Nutanix (NTNX) aligns with Minervini's trend strategy and high-growth momentum, showing strong technicals, rising earnings, and breakout potential. A top pick for growth investors.
BorgWarner beats Q2 earnings, raises full-year guidance, and hikes dividend by 55%. Strong profitability and new contracts drive growth. Stock up 4.5% pre-market.
PBF Energy reported mixed Q2 2025 results, with revenue beating estimates but EPS missing. The company declared a $0.275 dividend amid operational challenges. Stock shows muted pre-market movement.
Norwegian Cruise Line (NCLH) posted mixed Q2 2025 results, missing revenue estimates but meeting EPS targets. Stock rose 7.7% on strong demand and reaffirmed guidance.
Cryptocurrency-focused companies Coinbase Global Inc. and Strategy Inc. which are due to report their second-quarter earnings after Thursday's market close, have seen their stock performances diverge significantly lately.
Integra LifeSciences (IART) Q2 2025 earnings beat revenue and EPS estimates, but shares dipped pre-market. Strong performance in neurosurgery and wound care segments drives growth.
TreeHouse Foods (THS) beats Q2 2025 earnings with EPS of $0.17, exceeding estimates by 63%. Adjusted net sales and EBITDA also outperform, driving a 3.45% pre-market stock gain. Strong operational execution boosts investor confidence.
TAL Education Group (NYSE:TAL) reported Q1 FY2026 results with $575M revenue, missing estimates, but EPS of $0.07 beat forecasts. Shares rose 10.8% pre-market.
SNDL Inc. beats Q2 2025 estimates with $244.99M revenue and $0.014 EPS, driving a 4.17% pre-market stock surge. Positive operating income signals growth in the competitive cannabis market.
Biotech company Biogen (NASDAQ:BIIB) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.3% year on year to $2.65 billion. Its non-GAAP profit of $5.47 per share was 41.3% above analysts’ consensus estimates.
Cigna Group (NYSE:CI) beat Q2 revenue estimates but slightly missed on EPS, reaffirming full-year guidance. Shares rose 4.4% pre-market as investors focused on growth.
Teleflex (NYSE:TFX) beats Q2 2025 estimates with $780.9M revenue and $3.73 EPS, driving a 15.9% pre-market surge. Strong growth in medical tech sector.
Exponent Inc (EXPO) excels with high profitability, strong cash flow, and steady growth, making it a top pick for long-term quality investors under the Caviar Cruise strategy.
KBR Inc. reported mixed Q2 2025 results with $1.95B revenue (up 6% YoY but below estimates) and $0.91 EPS (beating forecasts). Shares dipped as revenue miss offset EPS beat.
